Robert F Storey Selected Research

Purinergic P2Y Receptor Antagonists

4/2019	Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine.
1/2019	Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y12 Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial.
6/2017	Relative efficacy and safety of ticagelor vs clopidogrel as a function of time to invasive management in non-ST-segment elevation acute coronary syndrome in the PLATO trial.
5/2015	Long-term use of ticagrelor in patients with prior myocardial infarction.
9/2014	Prehospital ticagrelor in ST-segment elevation myocardial infarction.
4/2014	Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trial.
12/2011	Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial.
6/2010	Relationship between degree of P2Y12 receptor blockade and inhibition of P2Y12-mediated platelet function.
11/2007	Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial.
11/2007	Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert F Storey Research Topics

Disease

126	Acute Coronary Syndrome 07/2022 - 09/2002
91	Myocardial Infarction 06/2022 - 11/2007
81	Hemorrhage 12/2022 - 11/2007
69	Thrombosis (Thrombus) 01/2022 - 03/2005
56	Stroke (Strokes) 01/2021 - 09/2009
31	ST Elevation Myocardial Infarction 06/2022 - 11/2007
26	Coronary Artery Disease (Coronary Atherosclerosis) 07/2022 - 11/2007
12	Diabetes Mellitus 01/2021 - 10/2010
12	Atrial Fibrillation 01/2021 - 09/2014
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 08/2010
9	Inflammation (Inflammations) 06/2022 - 04/2010
7	Dyspnea (Shortness of Breath) 01/2020 - 07/2010
7	Heart Failure 01/2019 - 12/2011
7	Vascular Diseases (Vascular Disease) 11/2018 - 08/2010
6	Peripheral Arterial Disease 06/2021 - 06/2015
6	Atherosclerosis 01/2020 - 10/2005
5	Coronary Disease (Coronary Heart Disease) 01/2021 - 04/2016
5	Chronic Renal Insufficiency 01/2019 - 09/2010
5	Ischemia 01/2018 - 01/2012
5	Atherosclerotic Plaque (Atheroma) 08/2017 - 04/2010
5	Infections 08/2015 - 10/2012
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 07/2022 - 01/2012
4	Type 2 Diabetes Mellitus (MODY) 05/2020 - 01/2017
4	Heart Diseases (Heart Disease) 12/2016 - 09/2002
3	Chest Pain (Chest Pains) 01/2022 - 04/2019
3	Ischemic Stroke 06/2021 - 09/2016
3	Sepsis (Septicemia) 01/2021 - 01/2014
3	Cardiac Arrhythmias (Arrythmia) 02/2019 - 10/2012
3	Sudden Death 11/2018 - 10/2012
3	Transient Ischemic Attack 09/2014 - 06/2012
2	Necrosis 06/2022 - 08/2015
2	COVID-19 01/2022 - 11/2021
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2021 - 01/2021
2	Cardiogenic Shock 01/2021 - 05/2013
2	Anemia 01/2021 - 04/2017
2	Endotoxemia 01/2021 - 04/2020
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 10/2015
2	Hypertension (High Blood Pressure) 01/2020 - 09/2014
2	AIDS-Related Complex (ARC) 01/2020 - 08/2015
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2020 - 12/2018
2	Hypoglycemia (Reactive Hypoglycemia) 01/2019 - 12/2018
2	Bradycardia 01/2018 - 05/2011

Drug/Important Bio-Agent (IBA)

127	TicagrelorIBA 04/2022 - 11/2007
76	Clopidogrel (Plavix)FDA Link 04/2022 - 09/2002
57	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2021 - 11/2007
21	Biomarkers (Surrogate Marker)IBA 06/2022 - 04/2010
12	Prasugrel Hydrochloride FDA Link 01/2021 - 06/2010
12	Purinergic P2Y Receptor AntagonistsIBA 04/2019 - 11/2002
10	Growth Differentiation Factor 15IBA 06/2022 - 01/2014
10	Pharmaceutical PreparationsIBA 01/2021 - 07/2010
9	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2022 - 01/2016
9	pro-brain natriuretic peptide (1-76)IBA 06/2022 - 01/2014
9	Brain Natriuretic Peptide (Natrecor)FDA Link 06/2022 - 07/2010
8	Troponin T (Troponin T1)IBA 06/2022 - 04/2016
8	omega-Chloroacetophenone (Mace)IBA 01/2020 - 01/2016
7	C-Reactive ProteinIBA 06/2022 - 04/2010
7	FibrinIBA 01/2021 - 04/2010
7	Cystatin CIBA 12/2019 - 01/2012
7	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2018 - 06/2008
6	TroponinIBA 07/2022 - 05/2016
6	Cytochrome P-450 CYP2C19IBA 01/2021 - 10/2010
6	AnticoagulantsIBA 01/2021 - 06/2008
6	Thrombin Receptors (Thrombin Receptor)IBA 01/2020 - 01/2012
6	vorapaxarIBA 01/2018 - 01/2012
5	Vitamin K FDA Link 01/2021 - 04/2016
5	Adenosine (Adenocard)FDA LinkGeneric 10/2020 - 08/2015
4	Trinitrotoluene (TNT)IBA 06/2022 - 01/2014
4	Fibrinogen (Factor I)FDA Link 01/2022 - 01/2017
4	apixabanIBA 01/2021 - 04/2016
4	MicroRNAs (MicroRNA)IBA 04/2020 - 09/2013
4	LipidsIBA 01/2020 - 08/2010
4	Morphine (MS Contin)FDA LinkGeneric 01/2020 - 01/2016
4	Glycoproteins (Glycoprotein)IBA 01/2020 - 09/2013
4	Adenosine Diphosphate (ADP)IBA 04/2019 - 04/2010
4	cangrelorIBA 09/2016 - 09/2002
4	CreatinineIBA 09/2013 - 09/2010
3	Interleukin-6 (Interleukin 6)IBA 06/2022 - 04/2010
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2021
3	Factor Xa (Coagulation Factor Xa)IBA 01/2021 - 06/2008
3	EndotoxinsIBA 01/2021 - 12/2015
3	Glucose (Dextrose)FDA LinkGeneric 05/2020 - 12/2018
3	RivaroxabanIBA 10/2019 - 04/2016
3	AR C124910XXIBA 05/2017 - 08/2015
2	N(2)-(3-trifluoromethylphenyl)guanineIBA 06/2022 - 07/2013
2	Enoxaparin (Lovenox)FDA LinkGeneric 05/2021 - 07/2018
2	Opiate AlkaloidsIBA 05/2021 - 07/2018
2	saxagliptin FDA Link 01/2021 - 01/2021
2	Complement C3 (C3 Complement)IBA 01/2021 - 12/2018
2	CholesterolIBA 11/2020 - 01/2020
2	Caffeine (No Doz)FDA LinkGeneric 01/2020 - 09/2015
2	Interleukin-18 (Interleukin 18)IBA 12/2019 - 06/2015
2	LigandsIBA 11/2019 - 05/2011
2	Platelet Membrane Glycoprotein IIbIBA 04/2019 - 02/2016
2	Tirofiban (Aggrastat)FDA Link 07/2018 - 06/2006

Therapy/Procedure

63	Therapeutics 07/2022 - 04/2009
43	Percutaneous Coronary Intervention 06/2022 - 06/2010
40	Stents 05/2021 - 11/2002
16	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 06/2021 - 09/2009
12	Secondary Prevention 01/2021 - 12/2011
2	Duration of Therapy 06/2021 - 09/2015